9
May

FDA Announces Birth Control Device May Put Women In Danger

May 09, 2012

May 9, 2012

New methods of birth control have allowed women greater freedom and choice, but some of these medications may put women at a greater risk of health issues. Take, for instance, one of the latest birth control methods to hit the market—NuvaRing®.

NuvaRing® is a plastic contraceptive device that’s inserted into a woman’s vagina monthly, where it slowly releases the hormones progestin and estrogen that control a woman’s ovulation cycle. After three weeks, the device is removed and the woman takes a one-week hiatus before inserting another device.

While NuvaRing® may be convenient for some women, it also has some side effects that could be deadly. According to an article from the Albany Times-Union, 950 lawsuits have been filed against the product’s maker, Merck & Co., alleging that using NuvaRing® led to health complications, such as blood clots. These blood clots, in certain cases, can lead to heart attack, stroke, and even death.

These lawsuits began piling in on the heels of a U.S. Food and Drug Administration announcement in October 2011 that stated using NuvaRing® increased the risk of suffering from blood clots by more than 56 percent compared to birth control pills.

These are not the only known NuvaRing® Dangers. That is why the Indiana Drug Injury Lawyers with Stewart and Stewart Injury Lawyers suggest discussing your case with an experienced attorney if you have suffered health complications after using NuvaRing®.